P10. An audit of prescribing of abciximab (Reopro~R) during percutaneous coronary intervention (PCI)

首页> 外文期刊>Pharmacy world & science: PWS >P10. An audit of prescribing of abciximab (Reopro~R) during percutaneous coronary intervention (PCI)

【24h】

P10. An audit of prescribing of abciximab (Reopro~R) during percutaneous coronary intervention (PCI)

机译：P10。经皮冠状动脉介入治疗（PCI）期间对abciximab（Reopro〜R）处方的审核

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Over a period of four months, use of abciximab in patients undergoing PCI at Kings' College Hospital showed excellent compliance with locally agreed guidelines derived from NICE criteria.

机译：在四个月的时间里，国王学院医院接受PCI的患者使用abciximab表现出对NICE标准的当地公认指南的极佳依从性。

著录项

来源
《Pharmacy world & science: PWS》 |2008年第3期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
abciximab; ReoPro; Cardio-; College;

机译：abciximab;ReoPro;Cardio-;大学;

相似文献

外文文献
中文文献
专利

1. P10. An audit of prescribing of abciximab (Reopro~R) during percutaneous coronary intervention (PCI) [J] . Pharmacy world & science: PWS . 2008,第3期

机译：P10。经皮冠状动脉介入治疗（PCI）期间对abciximab（Reopro〜R）处方的审核
2. Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro ? ), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention [J] . Doo Sun Sim, Myung Ho Jeong, Weon Kim, The Korean Journal of Internal Medicine . 2003,第3期

机译：血小板糖蛋白IIb / IIIa受体阻滞剂阿昔单抗（ReoPro？）在接受经皮冠状动脉介入治疗的高危糖尿病患者中的长期临床益处
3. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. [J] . Thiele H, Schindler K, Friedenberger J, Circulation: An Official Journal of the American Heart Association . 2008,第1期

机译：ST抬高型心肌梗死患者行冠脉内与静脉推注abciximab的比较，原发性经皮冠状动脉介入治疗：在ST抬高型心肌梗死试验中，随机莱比锡立即经皮冠状动脉介入治疗abciximab IV与IC对比。
4. Gender Differences in Percutaneous Coronary Intervention Outcomes from a Clinical Registry of 59,000 PCIs. [C] . Dobies D., Barber K., Cohoon A. World Congress on Heart Disease. . 2013

机译：59,000 pcis临床登记处的经皮冠状动脉干预结果的性别差异。
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study [O] . Daniel Kretzschmar, Christian Jung, Sylvia Otto, 2012

机译：多普勒超声在阿昔单抗辅助抗栓治疗下经皮冠状动脉介入治疗期间稳定型心绞痛患者冠状动脉微栓塞的检测：高强度瞬时信号ReoPro（HITS-RP）研究的设计和原理
7. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study [O] . Daniel Kretzschmar, Christian Jung, Sylvia Otto, 2012

机译：多普勒超声在阿昔单抗辅助抗栓治疗下经皮冠状动脉介入治疗期间稳定型心绞痛患者冠状动脉微栓塞的检测：高强度瞬时信号ReoPro（HITS-RP）研究的设计和原理

P10. An audit of prescribing of abciximab (Reopro~R) during percutaneous coronary intervention (PCI)

摘要

著录项

相似文献

相关主题

期刊订阅